TABLE 1.
Effect of costus treatments on cardiac enzyme levels in the different groups studied.
| Control | Costus | EST | EST₊Costus | |
|---|---|---|---|---|
| CPK (U/I) | 295.8# ± 6.24 | 278.4# ± 8.13 | 892* ± 5.15 | 629.4*# ± 8.96 |
| LDH 103 (U/I) | 1.435# ± 0.024 | 1.302# ± 0.011 | 10.05* ± 0.27 | 7.814#* ± 0.23 |
| CK-Mb (ug/ml) | 0.268# ± 0.008 | 0.227# ± 0.003 | 0.364* ± 0.006 | 0.323*# ± 0.008 |
| ALP (U/I) | 122.0# ± 6.88 | 112.5# ± 5.60 | 183.5* ± 9.54 | 151.8*# ± 6.29 |
| AST (U/I) | 95.2# ± 4.26 | 90.5# ± 4.974 | 209.4* ± 8.39 | 148.5*# ± 6.00 |
Data are expressed as mean ± SE of 10 observations. Where, EST, Ehrlich solid tumor; EST + Costus, treated Ehrlich solid tomor with Costus. Significant difference from the control group at *p < 0.05. Significant difference from the EST group at #p < 0.05.